Abrocitinib in atopic dermatitis: real-world effectiveness and safety up to 1 year

Abrocitinib in atopic dermatitis: real-world effectiveness and safety up to 1 yearRunning title: abrocitinib in atopic dermatitis up to one yearNiccolò Gori1,2, Maria Vittoria Cannizzaro1,2, Elena Ippoliti1,2, Marco Galluzzo3,4, Marina Talamonti,3,4, Edoardo Mortato3,4, Camilla Chello5, Ester Del Duca5, Giuseppe Gemma5, Ersilia Tolino6, Nicoletta Bernardini6, Nevena Skroza6, Giacomo Caldarola1,21Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy2U.O.C. Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione PoliclinicoUniversitario A. Gemelli IRCCS, Rome, Italy.3Department of Systems Medicine, University of Rome ”Tor Vergata”, 00133 Rome, Italy.4Dermatology Unit, Fondazione Policlinico Tor Vergata, 00133 Rome, Italy5Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Dermatology Clinic, Sapienza University of Rome, Rome, Italy.6Dermatology Unit ”Daniele Innocenzi”, ”A. Fiorini” Hospital, Terracina, Italy.